Showing 2281-2290 of 5616 results for "".
A Treatment for Schizophrenia in Adults
https://reachmd.com/industry-feature/psychiatry-and-mental-health/treatment-schizophrenia-adults/7535/Please see Important Safety Information, including Boxed Warning.Host Dr. Matt Birnholz and guest expert, Dr. Roger McIntyre...The Menopausal Patient: Clinical Pearls for Discovering and Managing Health Issues
https://reachmd.com/programs/partners-in-practice/the-menopausal-patient-clinical-pearls-for-discovering-and-managing-health-issues/7060/There are approximately 55 million women of menopausal age in the US. In fact, about 6,000 women reach menopausal age every day. For many, the spectrum of physical changes and their associated impacts on daily life aren't always anticipated or well understood. Clinicians of all levels have unique opUncovering Misperceptions About College Drinking
https://reachmd.com/programs/clinicians-roundtable/uncovering-misperceptions-about-college-drinking/4087/Most of us have fond memories of our college years. As we now see in our families and in our practices, and perhaps retrospectively in ourselves, the behavior of college students is often influenced by what is perceived to be normal among their peers. Looking more specifically at social norms researUnderstanding Bone Metastases in Breast Cancer: Impacts and Treatment Approaches
https://reachmd.com/programs/project-oncology/understanding-bone-metastases-in-breast-cancer-impacts-and-treatment-approaches/26406/Tune in to learn about the impacts and treatment of bone metastases in breast cancer patients.VNS: Beyond Seizure Control
https://reachmd.com/programs/cme/vns-beyond-seizure-control/35795/Tune in to learn about using vagus nerve stimulation (VNS) for the treatment of drug-resistant epilepsy (DRE) & treatment-resistant depression (TRD).Understanding Endocrine Resistance in HR+/HER2- mBC
https://reachmd.com/programs/cme/Understanding-Endocrine-Resistance-in-HR-HER2-mBC/37323/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.PI3K Pathway Inhibition in HR+/HER2- mBC: Mechanistic Insights
https://reachmd.com/programs/cme/PI3K-Pathway-inhibition-in-HR-HER2-mBC-Mechanistic-Insights/37329/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.The Metabolic Roots of Early-Onset Colorectal Cancer
https://reachmd.com/programs/project-oncology/metabolic-roots-early-onset-crc/49166/Early Liquid Biopsy in Advanced Lung Cancer: Real-World Data Suggest Targeted Gains
https://reachmd.com/programs/project-oncology/early-liquid-biopsy-in-advanced-lung-cancer-real-world-data-suggest-targeted-gains/39033/The Maternal Brain’s Role in Bone Health: Exploring CCN3’s Potential Power
https://reachmd.com/programs/frontlines-osteoporosis/the-maternal-brains-role-in-bone-health-exploring-cnn3s-potential-power/32343/Based on a recent study’s findings, CCN3 is a hormone released from the maternal brain that triggers skeletal stem cells to form new bone—a discovery that could transform osteoporosis treatment by targeting the condition at its root. Joining Ms. Ashley Baker to explore the key findings and clinical